Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New EU project looking at late side-effects of the treatment of childhood cancer

06.11.2013
Coordination by the Mainz University Medical Center / European Union provides funding of approximately EUR 6 million

Is it possible to predict the likelihood of subsequent complications following cancer treatment on the basis of genetic tests? This is the main question to be addressed by an EU-wide research project that is being coordinated by the German Childhood Cancer Registry at the Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI) of the Mainz University Medical Center.

The project will focus on late effects of the childhood tumor therapy, such as fertility problems and hearing loss. In addition, the researchers aim to determine the overall effect of these complications on the health-related quality of life of former patients. The European Union will be providing funding of some EUR 6 million to support the research project entitled PanCareLIFE.

The prognosis for survival of patients who develop cancer as children has significantly improved in the last decades. Depending on the diagnosis, some 80 percent of those afflicted now experience remission. However, the improvement in the rate of long-term survival has also resulted in an increase of the rate of those likely to suffer late complications. These complications can take various forms, such as damage to organs (e.g., heart, kidneys, ear), impairment of the quality of life (due to growth problems, physical disabilities, intellectual impairment, or difficulty with social integration), and an increased risk of second cancer.

Researchers from eight European countries, i.e., the Czech Republic, Denmark, France, Germany, Ireland, Italy, the Netherlands, and Switzerland, will be participating in the PanCareLIFE project. The data from a total of about 12,000 former patients from all participating countries will be analyzed. The researchers involved hope to be able to use this data to identify genetic and non-genetic risk factors that may be associated with fertility problems and deafness. They thus intend to study genetic material in order to determine which genetic variants may be associated with the above-mentioned complications. The data collected during the PanCareLIFE project will be collated centrally at the German Childhood Cancer Registry of IMBEI at the Medical Center of Johannes Gutenberg University Mainz (JGU).

"It is a great honor for us that we here in Mainz at IMBEI have been assigned the coordination of this project and the responsibilities for collation of this valuable European data and the main statistical analysis," said PD Dr. Peter Kaatsch, Project Coordinator and Head of the German Childhood Cancer Registry. Professor Maria Blettner, Director of IMBEI, added: "The fact that we have improved the rate of long-term cancer survival is a great achievement. At the same time, this necessarily means that we need to focus on the possible late complications. PanCareLIFE can make a significant contribution here to the improvement of the long-term quality of life of survivors."

The Chief Scientific Officer of the Mainz University Medical Center, Professor Ulrich Förstermann, emphasized that this project again demonstrates the significance assigned to epidemiological research at Mainz. "The University Medical Center with all its institutions is a key player in analyzing the emergence of diseases with their temporal and regional variations in a population, in exploring their development mechanisms, finding causes, preventing late complications, and initiating the corresponding preventative measures."

The German Childhood Cancer Registry has documented all cases of cancer occurring in children and adolescents in Germany since 1980. Some 50,000 cases have been recorded to date and more than 30,000 former patients are in long-term follow-up. The German Childhood Cancer Registry has been asked to act as coordinator for PanCareLIFE, a multinational research project initiated by the European Commission, due to its extensive experience with childhood cancer registration, familiarity with research into the causes and late complications of childhood cancer, and its international links with other institutions.

Contact
PD Dr. Peter Kaatsch, Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), Mainz University Medical Center
phone +49 6131 17–3111 / fax +49 6131 17-4462
e-mail: peter.kaatsch@unimedizin-mainz.de
Press contact
Oliver Kreft, Press and Public Relations, Mainz University Medical Center
phone +49 6131 17-7428 / fax +49 6131 17-3496
e-mail: pr@unimedizin-mainz.de
About the University Medical Center of Johannes Gutenberg University Mainz
The University Medical Center of Johannes Gutenberg University Mainz is the only facility of its kind in Rhineland-Palatinate. It consists of more than 60 clinics, institutes, and departments. Research and teaching are inextricably linked with medical treatment. Approximately 3,500 students of medicine and dentistry are trained in Mainz on a continuous basis. More information can be found at http://www.unimedizin-mainz.de/index.php?L=1

Petra Giegerich | idw
Further information:
http://www.unimedizin-mainz.de/index.php?L=1

More articles from Health and Medicine:

nachricht Chronic stress induces fatal organ dysfunctions via a new neural circuit
21.08.2017 | Hokkaido University

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Nagoya physicists resolve long-standing mystery of structure-less transition

21.08.2017 | Materials Sciences

Chronic stress induces fatal organ dysfunctions via a new neural circuit

21.08.2017 | Health and Medicine

Scientists from the MSU studied new liquid-crystalline photochrom

21.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>